NEFL and oculocutaneous albinism type 1: Plasma biomarkers of ATN (amyloid-β42/40, p-tau217, and neurofilament light; NfL) showed utility in improving the prediction of cognitive decline in cognitively unimpaired elderly populations [81,82].